{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:23Z","timestamp":1740123683638,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10875-020-00955-8","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T02:02:59Z","timestamp":1609898579000},"page":"585-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Complementary and Alternative Medicine in Patients with Primary Immunodeficiency: a Multicentric Analysis of 101 Patients"],"prefix":"10.1007","volume":"41","author":[{"given":"Anna S.","family":"Harasim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Krone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Tony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha","family":"Gawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Joos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gernert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henner","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-2092","authenticated-orcid":false,"given":"Eva C.","family":"Schwaneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"955_CR1","volume-title":"WHO global report on traditional and complementary medicine","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. WHO global report on traditional and complementary medicine. Geneva: World Health Organization; 2019."},{"issue":"5","key":"955_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000475549","volume":"24","author":"E Jansen","year":"2017","unstructured":"Jansen E. The role of complementary and alternative medicine in the healthcare system: a German paradox. Complement Med Res. 2017;24(5):290\u20134.","journal-title":"Complement Med Res"},{"issue":"6","key":"955_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000082814","volume":"11","author":"U H\u00e4rtel","year":"2004","unstructured":"H\u00e4rtel U, Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland\u2013Ergebnisse einer repr\u00e4sentativen Bev\u00f6lkerungsstudie. Complement Med Res. 2004;11(6):327\u201334.","journal-title":"Complement Med Res"},{"key":"955_CR4","doi-asserted-by":"crossref","unstructured":"Ernst E. The prevalence of complementary\/alternative medicine in cancer. Cancer. 1998;83(4):777\u201382.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/9708945\/.\u00a0Accessed 10 Sep 2020.","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O"},{"issue":"3","key":"955_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1534735411423920","volume":"11","author":"M Horneber","year":"2012","unstructured":"Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187\u2013203.","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"955_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/annonc\/mdi110","volume":"16","author":"A Molassiotis","year":"2005","unstructured":"Molassiotis A, Fern\u00e1ndez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655\u201363.","journal-title":"Ann Oncol"},{"issue":"2","key":"955_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bioe.12243","volume":"30","author":"K Smith","year":"2016","unstructured":"Smith K, Ernst E, Colquhoun D, Sampson W. Complementary & alternative medicine (CAM): ethical and policy issues. Bioethics. 2016;30(2):60\u20132.","journal-title":"Bioethics"},{"issue":"1","key":"955_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1533210105275144","volume":"10","author":"P Curtis","year":"2005","unstructured":"Curtis P, Gaylord S. Safety issues in the interaction of conventional, complementary, and alternative health care. Complement Health Pract Rev. 2005;10(1):3\u201331.","journal-title":"Complement Health Pract Rev"},{"issue":"6","key":"955_CR9","first-page":"480","volume":"21","author":"Y Karali","year":"2011","unstructured":"Karali Y, Saglam H, Karali Z, Kilic SS. The use of complementary and alternative medicine in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2011;21(6):480\u20133.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"955_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-017-0404-8","volume":"37","author":"NL Rider","year":"2017","unstructured":"Rider NL, Kutac C, Hajjar J, Scalchunes C, Seeborg FO, Boyle M, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017;37(5):461\u201375.","journal-title":"J Clin Immunol"},{"key":"955_CR11","unstructured":"Schmidt RE, Baumann U, Boztug K, Hennig C, Stoll M, Witte T. Prim\u00e4re und sekund\u00e4re Immundefekte. 3rd ed. Bremen: Uni-Med-Verlag; 2011.\u00a0"},{"key":"955_CR12","unstructured":"Franke K. Vitamin D und Immundefekt. In Brosch\u00fcren & Flyer. dsai. e.V. 2017.\u00a0https:\/\/www.dsai.de\/fileadmin\/user_upload\/Publikationen\/broschuere_vitamin-D_dsai_print_PDF.pdf.\u00a0Accessed 10 Sep 2020."},{"issue":"8","key":"955_CR13","first-page":"461","volume":"35","author":"CL Ventola","year":"2010","unstructured":"Ventola CL. Current issues regarding complementary and alternative medicine (CAM) in the United States: part 1: the widespread use of CAM and the need for better-informed health care professionals to provide patient counseling. P T. 2010;35(8):461\u20138.","journal-title":"P T"},{"issue":"8","key":"955_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00115-020-00945-6","volume":"91","author":"T H\u00f6rbelt","year":"2020","unstructured":"H\u00f6rbelt T, Hetze S, Schedlowski M, L\u00fcckemann L. Die gelernte Placeboantwort im Immunsystem. Nervenarzt. 2020;91(8):667\u201374.","journal-title":"Nervenarzt"},{"issue":"2","key":"955_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2008.12.023","volume":"123","author":"T Mainardi","year":"2009","unstructured":"Mainardi T, Kapoor S, Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol. 2009;123(2):283\u201394 quiz 295-6.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12906-015-0569-8","volume":"15","author":"S Italia","year":"2015","unstructured":"Italia S, Brand H, Heinrich J, Berdel D, von Berg A, Wolfenstetter SB. Utilization of complementary and alternative medicine (CAM) among children from a German birth cohort (GINIplus): patterns, costs, and trends of use. BMC Complement Altern Med. 2015;15:49.","journal-title":"BMC Complement Altern Med"},{"key":"955_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1472-6963-8-127","volume":"8","author":"S Joos","year":"2008","unstructured":"Joos S, Musselmann B, Miksch A, Rosemann T, Szecsenyi J. The role of complementary and alternative medicine (CAM) in Germany-a focus group study of GPs. BMC Health Serv Res. 2008;8:127.","journal-title":"BMC Health Serv Res"},{"key":"955_CR18","doi-asserted-by":"crossref","unstructured":"Mahler C, Hermann K, Horne R, Ludt S, Haefeli WE, Szecsenyi J et al. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J Eval Clin Pract 2010;16(3):574\u20139.","DOI":"10.1111\/j.1365-2753.2009.01169.x"},{"key":"955_CR19","doi-asserted-by":"publisher","unstructured":"Franke GH, M\u00e4hner N, Reimer N, Spangemacher B, Esser J. EFK. Essener Fragebogen zur Krankheitsverarbeitung [Verfahrensdokumentation aus PSYNDEX Tests-Nr. 9004126, Autorenbeschreibung, Fragebogen und Auswertung (Item-Skalenzuordnung)]. Trier: ZPID. 2010. https:\/\/doi.org\/10.23668\/psycharchives.343","DOI":"10.23668\/psycharchives.343"},{"issue":"2","key":"955_CR20","first-page":"166","volume":"21","author":"GH Franke","year":"2000","unstructured":"Franke GH, M\u00e4hner N, Reimer J, Spangemacher B, Esser J. Erste \u00dcberpr\u00fcfung des Essener Fragebogens zur Krankheitsverarbeitung (EFK) an sehbeeintr\u00e4chtigten Patienten. ZDDP. 2000;21(2):166\u201372.","journal-title":"ZDDP."},{"issue":"3","key":"955_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"Topp CW, \u00d8stergaard SD, S\u00f8ndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167\u201376.","journal-title":"Psychother Psychosom"},{"key":"955_CR22","unstructured":"Psychiatric Research Unit. The World Health Organization-Five Well-Being Index (WHO-5). In:\u00a0WHO-5 Questionnaires.\u00a0Frederiksborg General Hospital, Hiller\u00f8d. 1998.\u00a0https:\/\/www.psykiatri-regionh.dk\/who-5\/who-5-questionnaires\/Pages\/default.aspx. Accessed 10 Sep 2020."},{"issue":"9","key":"955_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"955_CR24","first-page":"45","volume":"12","author":"M Frass","year":"2012","unstructured":"Frass M, Strassl RP, Friehs H, M\u00fcllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J. 2012;12(1):45\u201356.","journal-title":"Ochsner J"},{"issue":"1","key":"955_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ecam\/nen023","volume":"7","author":"FL Bishop","year":"2010","unstructured":"Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med. 2010;7(1):11\u201328.","journal-title":"Evid Based Complement Alternat Med"},{"key":"955_CR26","unstructured":"May U, Bauer C, Wasem J. Marktabgrenzung und volkswirtschaftlicher Stellenwert von Naturheilmitteln in Deutschland. In: IBES Diskussionsbeitrag. Essen; 2015 210.\u00a0http:\/\/hdl.handle.net\/10419\/118684. Accessed 10 Sep 2020."},{"issue":"9","key":"955_CR27","doi-asserted-by":"publisher","first-page":"e0132562","DOI":"10.1371\/journal.pone.0132562","volume":"10","author":"M Browne","year":"2015","unstructured":"Browne M, Thomson P, Rockloff MJ, Pennycook G. Going against the herd: psychological and cultural factors underlying the \u2018vaccination confidence gap\u2019. PLoS One. 2015;10(9):e0132562.","journal-title":"PLoS One"},{"key":"955_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.socscimed.2017.11.022","volume":"196","author":"K Attwell","year":"2018","unstructured":"Attwell K, Ward PR, Meyer SB, Rokkas PJ, Leask J. \u201cDo-it-yourself\u201d: vaccine rejection and complementary and alternative medicine (CAM). Soc Sci Med. 2018;196:106\u201314.","journal-title":"Soc Sci Med"},{"issue":"4","key":"955_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/1403494817733869","volume":"46","author":"LM Kemppainen","year":"2018","unstructured":"Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: health-related and sociodemographic determinants. Scand J Public Health. 2018;46(4):448\u201355.","journal-title":"Scand J Public Health"},{"issue":"4","key":"955_CR30","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7314\/APJCP.2016.17.4.2115","volume":"17","author":"Y Azhar","year":"2016","unstructured":"Azhar Y, Achmad D, Lukman K, Hilmanto D, Aryandono T. Predictors of complementary and alternative medicine use by breast cancer patients in Bandung, Indonesia. Asian Pac J Cancer Prev. 2016;17(4):2115\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"955_CR31","unstructured":"Mossailos E, Djordjevic A, Osborn R, Sarnak D. International profiles of health care systems: Australia, Canada, China, Denmark, England, France, Germany, India, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Singapore, Sweden, Switzerland, Taiwan, and the United States. In: The Commonwealth Fund; 2017. https:\/\/www.commonwealthfund.org\/publications\/fund-reports\/2017\/may\/international-profiles-health-care-systems. Accessed 10 Sep 2020."},{"issue":"9","key":"955_CR32","doi-asserted-by":"publisher","first-page":"e0182897","DOI":"10.1371\/journal.pone.0182897","volume":"12","author":"JK Ostermann","year":"2017","unstructured":"Ostermann JK, Witt CM, Reinhold T. A retrospective cost-analysis of additional homeopathic treatment in Germany: long-term economic outcomes. PLoS One. 2017;12(9):e0182897.","journal-title":"PLoS One"},{"issue":"1","key":"955_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/acm.2012.0762","volume":"20","author":"AP Sim\u00f5es-W\u00fcst","year":"2014","unstructured":"Sim\u00f5es-W\u00fcst AP, Rist L, Dettling M. Self-reported health characteristics and medication consumption by CAM users and nonusers: a Swiss cross-sectional survey. J Altern Complement Med. 2014;20(1):40\u20137.","journal-title":"J Altern Complement Med"},{"issue":"4","key":"955_CR34","first-page":"207","volume":"11","author":"R Huber","year":"2004","unstructured":"Huber R, L\u00fcdtke R, Beiser I, Koch D. Coping strategies and the request for a consultation on complementary and alternative medicine-a cross-sectional survey of patients in a psychosomatic and three medical departments of a German university hospital. Forsch Komplementarmed Klass Naturheilkd. 2004;11(4):207\u201311.","journal-title":"Forsch Komplementarmed Klass Naturheilkd"},{"issue":"1","key":"955_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000450645","volume":"26","author":"J Huebner","year":"2017","unstructured":"Huebner J, Prott FJ, Muecke R, Stoll C, Buentzel J, Muenstedt K, et al. Economic evaluation of complementary and alternative medicine in oncology: is there a difference compared to conventional medicine? Med Princ Pract. 2017;26(1):41\u20139.","journal-title":"Med Princ Pract"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-020-00955-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:19:28Z","timestamp":1697501968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-020-00955-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00955-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Anna S. Harasim, Manuel Krone, Micha Gawlik, and Stefanie Joos have no conflicts of interest. Hans-Peter Tony has received honoraria for consultation from Takeda\/Shire. Torsten Witte has received honoraria for speaking at symposia from CSL Behring, Octapharma, and Shire. Michael Gernert has received financial support for attending symposia from AbbVie, Chugai, Hexal, Janssen, Lilly, Pfizer, and Roche. Marc Schmalzing has received honoraria for speaking at symposia, financial support for attending symposia, and research grants and honoraria for consultation from Baxalta. Henner Morbach has received honoraria for speaking at symposia from Shire\/Takeda, CSL Behring; and honoraria for consultation from Shire\/Takeda. Eva C. Schwaneck has received honoraria for speaking at symposia, financial support for attending symposia, and research grants and honoraria for consultation from Baxalta\/Shire\/Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Approval was obtained from the ethics committees of University of W\u00fcrzburg (file number 147\/18-sc) and University of Hanover (file number 8279_BO_K_2019). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate and Publish"}}]}}